Digital CPV Tools for Automated Alerting, Case Creation and Workflow Routing Digital CPV Tools for Automated Alerting, Case Creation and Workflow Routing Continued Process Verification (CPV) is an essential component of modern pharmaceutical and biopharmaceutical quality practices. As global regulatory expectations evolve, organizations are increasingly leveraging digital tools to enhance their CPV efforts. This article explores the critical role of digital CPV tools, particularly their capabilities for automated alerting, case creation, and workflow routing in relation to US FDA and EU EMA regulatory frameworks. Understanding CPV Triggers for CAPA and Revalidation Continued Process Verification (CPV) encompasses real-time assessments of manufacturing…

Examples of CPV Signals that Triggered Major Process Improvement Projects Examples of CPV Signals that Triggered Major Process Improvement Projects Continued Process Verification (CPV) is crucial for ensuring that pharmaceutical manufacturing processes remain in a state of control throughout the product lifecycle. Regulatory bodies such as the FDA, the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA) emphasize the importance of CPV signals in maintaining compliance and promoting quality enhancement. This article delves into various examples of CPV signals that have prompted significant process improvement projects, beneficial for professionals in regulatory affairs, quality assurance, and…

Using CPV to Support or Challenge Existing Control Limits and Specifications Using CPV to Support or Challenge Existing Control Limits and Specifications Continued Process Verification (CPV) represents a vital component in the lifecycle management of pharmaceutical manufacturing. By systematically monitoring and analyzing process data, CPV aids in supporting or challenging existing control limits and specifications, ultimately ensuring product quality and compliance with regulatory standards. This regulatory explainer manual provides an in-depth exploration of CPV, its triggers for Corrective and Preventive Action (CAPA), and revalidation processes, while aligning with best practices defined by the FDA, EMA, and MHRA. 1. Understanding Continued…

Building a culture that takes CPV signals seriously and acts decisively Building a culture that takes CPV signals seriously and acts decisively In the realm of pharmaceutical manufacturing and quality assurance, Continued Process Verification (CPV) has emerged as a pivotal strategy to ensure the effectiveness and reliability of processes throughout the product lifecycle. As regulatory expectations evolve, organizations must adapt to integrate CPV effectively into their operations. This involves a cultural shift that encourages teams to take CPV signals seriously and respond decisively when alarms are triggered. Understanding CPV and Its Importance in Lifecycle Management Continued Process Verification refers to…

Future of CPV Triggers: Dynamic, Self-Learning, and AI-Adjusted Thresholds Future of CPV Triggers: Dynamic, Self-Learning, and AI-Adjusted Thresholds Continued Process Verification (CPV) is an essential component in the lifecycle management of pharmaceutical products, ensuring that processes remain in control and product quality is consistently maintained. One of the critical areas within CPV is the establishment of effective triggers for Corrective and Preventive Actions (CAPA) and revalidation. As the industry evolves, integrating advanced technologies such as artificial intelligence (AI) presents new opportunities to enhance CPV triggers, making them dynamic, self-learning, and adaptable to real-time data and process changes. Understanding Continued Process…

Integrating CPV Events into Change Control Decision Processes Integrating CPV Events into Change Control Decision Processes In the highly regulated pharmaceutical industry, the integration of Continued Process Verification (CPV) events into change control decision processes is critical for ensuring compliance and maintaining product quality. Regulatory authorities, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA), emphasize the importance of robust quality systems. This article will provide a comprehensive overview of how CPV events can inform change control processes, focusing on CPV triggers for Corrective and Preventive Actions…

Using CPV Triggers as Inputs to Annual Product Review and Risk Review Meetings Using CPV Triggers as Inputs to Annual Product Review and Risk Review Meetings In the pharmaceutical industry, continued process verification (CPV) is a critical aspect of product lifecycle management. As regulatory scrutiny intensifies, especially from agencies such as the FDA, European Medicines Agency (EMA), and Medicines and Healthcare products Regulatory Agency (MHRA), it becomes essential for companies to effectively use CPV triggers in the context of their annual product reviews (APR) and risk review meetings. This article aims to dissect the integration of CPV triggers for corrective…

Global expectations FDA, EMA and MHRA on CPV link to lifecycle management Global Expectations of FDA, EMA, and MHRA on Continued Process Verification and its Link to Lifecycle Management Continued Process Verification (CPV) has emerged as a critical component in the regulatory framework governing pharmaceutical manufacturing. Regulatory authorities such as the FDA (Food and Drug Administration), EMA (European Medicines Agency), and MHRA (Medicines and Healthcare products Regulatory Agency) have laid down comprehensive guidelines that extend beyond traditional Quality by Design (QbD) principles. This article elucidates the expectations from these regulatory bodies regarding CPV, particularly in relation to lifecycle management, CAPA…

How to Document CPV Based Revalidation Rationales for Inspectors How to Document CPV Based Revalidation Rationales for Inspectors In the increasingly complex landscape of pharmaceutical manufacturing and quality assurance, Continued Process Verification (CPV) has emerged as an essential component of ensuring product quality and compliance with regulatory standards across various jurisdictions, including the FDA in the United States, EMA in the European Union, and MHRA in the United Kingdom. Understanding how to document CPV-based revalidation rationales is critical for organizations aiming to maintain compliance and facilitate smooth inspections. This article delineates the practices necessary for effectively recording rationales linked to…

Internal Audits Focused on Evidence of CPV Based Investigations and CAPA Internal Audits Focused on Evidence of CPV Based Investigations and CAPA Introduction to Continued Process Verification (CPV) Continued Process Verification (CPV) is a crucial component within the lifecycle management of pharmaceutical products, ensuring consistency and compliance throughout manufacturing processes. As defined by the FDA under 21 CFR Part 211.100, CPV involves the ongoing verification of product and process characteristics through data collection and analysis, which aids in maintaining product quality and meeting regulatory requirements. With the advent of modern quality practices, the concept of CPV has evolved into a…